Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis.

Journal of Experimental & Clinical Cancer Research : CR
Yuan XuGao-Lin Liu

Abstract

Antiangiogenic therapy is one of the most significant advances in anticancer treatment. The benefits of antiangiogenic therapies of late-stage cancers have been investigated but are still too limited. We used an ovarian cancer model to test the effect of short-term bevacizumab treatment on metastasis as measured by bioluminescence. Western blotting and CD34-PAS dual staining were performed to assess hypoxia-inducible transcription factor-1α (HIF-1α) expression and vasculogenic mimicry(VM) formation. Cell viability was examined by a CCK8 assay. Bevacizumab demonstrated antitumor effects in models of ovarian cancer, but also accelerated metastasis together, with marked hypoxia and VM formation in mice receiving short-term therapy. Bevacizumab treatment did not affect SKOV3 cell viability and the amount of VM in three-dimensional culture. These results suggest that antiangiogenic therapy may potentially influence the progression of metastatic disease, which has been linked to the hypoxic response and VM formation.

References

Nov 18, 1971·The New England Journal of Medicine·J Folkman
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Sep 17, 1999·The American Journal of Pathology·A J ManiotisM J Hendrix
Sep 27, 2000·Neoplasia : an International Journal for Oncology Research·J L RubensteinM A Shuman
Feb 28, 2002·Biochemical and Biophysical Research Communications·L Van RompaeyG Grosveld
Mar 1, 2002·British Journal of Cancer·E PassalidouF Pezzella
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Kazuo ShirakawaFumio Konishi
May 3, 2003·Cancer Cell·Selma PennacchiettiPaolo M Comoglio
Jun 6, 2003·Oncogene·Mary J C HendrixRichard E B Seftor
May 1, 2004·American Journal of Obstetrics and Gynecology·Anil K SoodMary J C Hendrix
Dec 17, 2005·Cancer Research·Daisy W J van der SchaftArjan W Griffioen
Mar 22, 2006·Expert Opinion on Therapeutic Targets·Gregg L Semenza
Feb 20, 2007·Cancer Letters·Shiwu ZhangBaocun Sun
May 9, 2008·The New England Journal of Medicine·Robert S Kerbel
Sep 9, 2009·Journal of Experimental & Clinical Cancer Research : CR·Rihong CongBin Wang
Feb 19, 2010·Human Gene Therapy·Haritha SamaranayakeSeppo Ylä-Herttuala
Mar 6, 2010·Cancer Chemotherapy and Pharmacology·Martin PölcherChristian Rudlowski

❮ Previous
Next ❯

Citations

Jan 15, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Liang LiWenjing Hou
Nov 30, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yuling CuiZihan Sun
May 20, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zihan SunZhiqiang Fan
Aug 13, 2015·International Journal of Molecular Sciences·Lisha QiBaocun Sun
Jan 26, 2016·Pharmacology & Therapeutics·Mary J C HendrixYi-Wen Chu
Dec 26, 2015·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Manuel Linder, Thomas Tschernig
Jun 1, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Nan YaoJian Zhang
May 3, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shuixian LiXiuzhen Han
Sep 9, 2016·International Journal of Molecular Sciences·Mauricio P PintoGareth I Owen
Aug 30, 2014·Cytokine & Growth Factor Reviews·Stijn MoensPeter Carmeliet
Aug 14, 2018·The Journal of Pathology·Victor Ljl ThijssenArjan W Griffioen
Feb 6, 2019·International Journal of Molecular Sciences·Stephan Niland, Johannes A Eble
Apr 5, 2019·In Vitro Cellular & Developmental Biology. Animal·Wenzhen WeiLinlin Hao
Feb 17, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Yun-Yan LuanHong-Sheng Yu
Oct 16, 2015·Journal of Experimental & Clinical Cancer Research : CR·Qingfeng XiangYajin Chen
Feb 27, 2016·International Journal of Urology : Official Journal of the Japanese Urological Association·Faming ZhangShaopeng Qiu
Jun 6, 2020·Journal of Experimental & Clinical Cancer Research : CR·Marta Di MartileDaniela Trisciuoglio
Dec 31, 2014·World Journal of Gastroenterology : WJG·Na-Na TangRui-Hua Shi
Mar 15, 2015·Pharmacological Reviews·Judy R van BeijnumArjan W Griffioen
Jan 31, 2017·International Journal of Molecular Sciences·Francesca Angiolini, Ugo Cavallaro
Aug 11, 2020·Frontiers in Cell and Developmental Biology·Christopher Montemagno, Gilles Pagès
Nov 23, 2019·Cell Death & Disease·Hai-Ping CaiZhong-Ping Chen
May 20, 2020·Molecular Biology Reports·Nazila Fathi MaroufiMohammad Nouri
Sep 1, 2015·Asian Pacific Journal of Tropical Medicine·Zhan-Wu YuYong-Yu Liu
Sep 1, 2017·BMC Cancer·Zhiyong LiuBaocun Sun
May 3, 2018·Journal of Experimental & Clinical Cancer Research : CR·Concetta SaponaroAnita Mangia
Oct 16, 2019·Frontiers in Oncology·Lízbeth Ayala-DomínguezMarcela Lizano
May 8, 2020·International Journal of Molecular Sciences·Dorcas Akuba-Muhyia AnnanKyoko Hida

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence microscopy
protein assay
xenografts

Software Mentioned

SPSS

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.